Profound Medical (PROF) Gross Margin (2024 - 2026)

Profound Medical's Gross Margin history runs 3 years deep, the most recent figure standing at 71.8% for Q1 2026.

• On a quarterly basis, Gross Margin rose 110.0% year-over-year to 71.8% in Q1 2026; TTM through Mar 2026 was 71.95%, a 554.0% increase from a year earlier, with the FY2025 full-year figure at 70.77%, up 488.0% from the prior year.
• Gross Margin improved to 71.8% in Q1 2026 per PROF's latest filing, from 66.77% in the prior quarter.
• Across five years, Gross Margin topped out at 77.7% in Q3 2025 and bottomed at 59.65% in Q4 2024.
• The 3-year median for Gross Margin is 71.04% (2024), against an average of 70.44%.
• Biggest YoY gain for Gross Margin was 736 bps in 2025; the steepest drop was 34 bps in 2025.
• Year by year, Gross Margin stood at 59.65% in 2024, then gained by 12 bps to 66.77% in 2025, then gained by 8 bps to 71.8% in 2026.
• Per Business Quant, the three latest PROF Gross Margin figures stand at 71.8% (Q1 2026), 66.77% (Q4 2025), and 77.7% (Q3 2025).